# Keros Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Oct 15, 2025

- Company: [Keros Therapeutics, Inc.](/companies/kros.md) (CIK 1664710)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-15
- Accepted by EDGAR: Oct 15, 2025, 06:50 ET
- Period: not reported
- Accession: 0000902664-25-004410
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1664710/000090266425004410/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1664710/000090266425004410/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1664710/000090266425004410/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 15, 2025.
Source: SEC EDGAR, the filing index for accession 0000902664-25-004410. Last ingested by Listed: Oct 27, 2026, 16:11 ET. No prices; not investment advice.